Atlas Trials

Phase 1 Trial of Ebola Vaccine in Mali

Clinical trial NCT02267109 · COMPLETED

Trial details

NCT number
NCT02267109
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Virus DiseaseHemorrhagic Fever
Start date
2014-10-01
Primary completion
2016-04-20
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.